1-2 of 2
Christopher Chiu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

Maissa Mhibik, Erika M. Gaglione, David Eik, John Herrick, Janet Le, Inhye E. Ahn, Christopher Chiu, Monica Wielgos-Bonvallet, Ida H. Hiemstra, Esther C. W. Breij, Jenny Chen, Edward B. Reilly, Pearlie K. Epling-Burnette, Edith Szafer-Glusman, Clare Sun, Adrian Wiestner
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4089–4101.
https://doi.org/10.1182/bloodadvances.2022009517
Published: 2023
Includes: Supplemental data
Journal Articles

Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma

Clinical Trials & Observations
Tineke Casneuf, Xu Steven Xu, Homer C. Adams, III, Amy E. Axel, Christopher Chiu, Imran Khan, Tahamtan Ahmadi, Xiaoyu Yan, Sagar Lonial, Torben Plesner, Henk M. Lokhorst, Niels W. C. J. van de Donk, Pamela L. Clemens, A. Kate Sasser
Journal: Blood Advances
Blood Adv (2017) 1 (23): 2105–2114.
https://doi.org/10.1182/bloodadvances.2017006866
Published: 2017
Includes: Supplemental data